Origin Agritech Holds Successful 2025 R&D and Business Management Conference
Origin Agritech (NASDAQ: SEED) held its 2025 R&D and Business Management Conference in Beijing, gathering industry experts and company leadership to discuss corporate strategy and China's seed industry development. Dr. Gengchan Han, Chairman, presented the company's vision to establish three platforms: technology development and cooperation, profit-sharing, and innovation.
CEO Weibin Yan highlighted opportunities in China's seed industry and outlined key projects, including the commercialization of GMO trait BBL2-2 approved in 2024, gene-editing technology advancement, and seed processing facility improvements. The company announced its 2025 strategy focusing on strengthening its seed business, expanding biotechnology capabilities, and exploring nutritional food businesses.
Origin Agritech (NASDAQ: SEED) ha tenuto la sua Conferenza sulla Ricerca e Sviluppo e Gestione Aziendale 2025 a Pechino, riunendo esperti del settore e i vertici aziendali per discutere la strategia aziendale e lo sviluppo dell'industria sementiera in Cina. Dr. Gengchan Han, Presidente, ha presentato la visione dell'azienda di stabilire tre piattaforme: sviluppo e cooperazione tecnologica, condivisione dei profitti e innovazione.
Il CEO Weibin Yan ha evidenziato le opportunità nell'industria sementiera cinese e ha delineato progetti chiave, tra cui la commercializzazione del carattere OGM BBL2-2 approvato nel 2024, i progressi nella tecnologia di editing genetico e i miglioramenti degli impianti di lavorazione dei semi. L'azienda ha annunciato la sua strategia per il 2025, concentrandosi sul rafforzamento del proprio business sementiero, sull'espansione delle capacità biotecnologiche e sull'esplorazione di imprese nel settore alimentare nutrizionale.
Origin Agritech (NASDAQ: SEED) llevó a cabo su Conferencia de I+D y Gestión Empresarial 2025 en Pekín, reuniendo a expertos de la industria y líderes de la empresa para discutir la estrategia corporativa y el desarrollo de la industria de semillas en China. Dr. Gengchan Han, Presidente, presentó la visión de la empresa de establecer tres plataformas: desarrollo y cooperación tecnológica, reparto de beneficios e innovación.
El CEO Weibin Yan destacó las oportunidades en la industria de semillas de China y delineó proyectos clave, incluyendo la comercialización de la característica OGM BBL2-2 aprobada en 2024, el avance en la tecnología de edición genética y las mejoras en las instalaciones de procesamiento de semillas. La empresa anunció su estrategia para 2025, enfocándose en fortalecer su negocio de semillas, expandir sus capacidades biotecnológicas y explorar negocios de alimentos nutricionales.
Origin Agritech (NASDAQ: SEED)는 베이징에서 2025년 연구개발 및 사업 관리 회의를 개최하여 업계 전문가와 회사 리더들이 모여 기업 전략과 중국의 종자 산업 발전에 대해 논의했습니다. Dr. Gengchan Han 회장은 기술 개발 및 협력, 이익 공유 및 혁신이라는 세 가지 플랫폼을 구축하는 회사의 비전을 제시했습니다.
CEO Weibin Yan은 중국의 종자 산업에서의 기회를 강조하고 2024년에 승인된 GMO 특성 BBL2-2의 상용화, 유전자 편집 기술 발전 및 종자 가공 시설 개선을 포함한 주요 프로젝트를 개괄했습니다. 이 회사는 종자 사업 강화, 생명공학 역량 확장 및 영양 식품 사업 탐색에 초점을 맞춘 2025년 전략을 발표했습니다.
Origin Agritech (NASDAQ: SEED) a tenu sa Conférence sur la recherche et développement et la gestion des affaires 2025 à Pékin, rassemblant des experts du secteur et des dirigeants d'entreprise pour discuter de la stratégie d'entreprise et du développement de l'industrie des semences en Chine. Dr. Gengchan Han, Président, a présenté la vision de l'entreprise consistant à établir trois plateformes : développement et coopération technologique, partage des bénéfices et innovation.
Le PDG Weibin Yan a souligné les opportunités dans l'industrie des semences en Chine et a posé les grandes lignes de projets clés, y compris la commercialisation du trait OGM BBL2-2 approuvé en 2024, l'avancement de la technologie d'édition génétique et les améliorations des installations de traitement des semences. L'entreprise a annoncé sa stratégie pour 2025, axée sur le renforcement de son activité semencière, l'expansion de ses capacités biotechnologiques et l'exploration d'entreprises alimentaires nutritives.
Origin Agritech (NASDAQ: SEED) hielt seine Konferenz für Forschung und Entwicklung sowie Unternehmensführung 2025 in Peking ab, bei der Branchenexperten und Unternehmensleiter zusammenkamen, um die Unternehmensstrategie und die Entwicklung der Saatgutindustrie in China zu erörtern. Dr. Gengchan Han, Vorsitzender, präsentierte die Vision des Unternehmens, drei Plattformen zu etablieren: technologische Entwicklung und Kooperation, Gewinnbeteiligung und Innovation.
CEO Weibin Yan hob die Chancen in der chinesischen Saatgutindustrie hervor und skizzierte Schlüsselprojekte, darunter die Kommerzialisierung des GMO-Traits BBL2-2, das 2024 genehmigt wurde, Fortschritte in der Gentechnik und Verbesserungen der Saatgutverarbeitungsanlagen. Das Unternehmen kündigte seine Strategie für 2025 an, die sich auf die Stärkung des Saatgutgeschäfts, die Erweiterung der biotechnologischen Fähigkeiten und die Erkundung von Nahrungsmittelunternehmen konzentriert.
- Received approval for GMO trait BBL2-2 in 2024
- Strategic expansion into biotechnology and nutritional food businesses
- Plans for improvement of seed processing facilities
- Development of three new strategic platforms
- Current need for seed business recovery indicates existing operational challenges
The conference focused on Origin Agritech's corporate strategy for 2025 and the overall development of
Key Highlights from the Conference:
- Chairman's Vision: Dr. Gengchan Han, Chairman of Origin Agritech, outlined the Company's vision to establish three platforms: a technology development and cooperation platform, a profit-sharing platform, and an innovation platform.
- CEO's Perspective: Mr. Weibin Yan, CEO of Origin Agritech, emphasized the significant opportunities in
China's seed industry and the Company's ambition to become a leading player inAsia , including the overall research and development key projects, pathway for the commercialization of the GMO trait BBL2-2 as approved in 2024, the Gene-editing technology, and the improvement of the seed processing facilities of the Company seed sales planning for the next season. - Industry Insights: Experts provided valuable insights into
China's corn industry's current state and future trends, highlighting the importance of "easy seed production" and the potential of bio-breeding. - Strategic Goals: Origin Agritech announced its 2025 corporate development strategy, including its vision, values, market positioning, and slogan. The Company aims to strengthen its seed business, expand its biotechnology platform capabilities, and explore new nutritional food businesses.
Looking Ahead:
Origin Agritech is committed to becoming a trusted leader in
Weibin Yan, Chief Executive Officer of Origin Agritech, commented: "Origin Agritech is poised to capitalize on the vast opportunities in
About Origin Agritech Limited
Origin Agritech Limited, founded in 1997 and headquartered in Zhong-Guan-Cun (ZGC) Life Science Park in
For more information, please contact:
Origin Agritech Limited Contact:
Kate Lang (Mandarin/English)
Director of Investor Relations
Phone: +86 186-1839-3368
Email: bing.lang@originseed.com.cn
Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/origin-agritech-holds-successful-2025-rd-and-business-management-conference-302333377.html
SOURCE Origin Agritech Limited
FAQ
What are Origin Agritech's (SEED) main strategic goals for 2025?
What is the significance of Origin Agritech's BBL2-2 GMO trait approval in 2024?
What are the three platforms announced by Origin Agritech's Chairman?